Several studies have found that hematogenic stem cell transplantation is an effective disease modifying therapy however the literature regarding prodromal and early symptoms <i>CSF1R</i>-related leukoencephalopathy is limited. The gene discussed is CSF1R; the disease is Leukoencephalopathy.